ArticleOncotarget2017

The anti-tumor efficacy of 3C23K, a glyco-engineered humanized anti-MISRII antibody, in an ovarian cancer model is mainly mediated by engagement of immune effector cells.

Pauline Estupina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.